Table 1.
Summary of oblast-level measures for 27 Ukrainian oblasts
| Data source | Mean | SD | Range | |
|---|---|---|---|---|
| Estimated size of PWID population | SYREX | 11,955·6 | 10650·7 | 1400 – 42000 |
| New registered HIV cases per 100,000 population1 | Ukraine Ministry of Health | 39·1 | 28·0 | 6·6 – 109·4 |
| HIV prevalence in pregnant women1 | Ukraine Ministry of Health | 0·325 | 0·198 | 0·07 – 0·74 |
| HIV prevalence among PWID aged <25 years | Ukraine Ministry of Health | 0·048 | 0·063 | 0 – 0·283 |
| Percent of PWID among newly diagnosed HIV cases | Ukraine Ministry of Health | 24·2% | 54·3% | 1·2 – 39·8% |
| Total number of syringes distributed | SYREX | 2,835,902 | 3,718,133 | 295,363 – 76,569,348 |
| Syringes per PWID2 | SYREX | 200·4 | 96·4 | 55·3 – 422·9 |
| Proportion of PWID on MAT1,2 | SYREX | 0·028 | 0·022 | 0·008 – 0·086 |
| Self-reported ART coverage of PWID | IBBS | 34·2% | 17·3% | 1·5 – 70·0% |
| Self-reported receipt of clean syringes/needles | IBBS | 49·2% | 19·4% | 15·5 – 97·1% |
| Self-reported client of a prevention program | IBBS | 34·7% | 21·9% | 6·1 – 96·1% |
1
N=25; data missing from the Autonomous Region of Crimea and Sebastopol City
2
Calculated variable
ARV = antiretroviral therapy; MAT = medication-assisted therapy; PWID = people who inject drugs